期刊文献+

上海部分地区30年女性乳腺癌发生的临床病理学差异比较 被引量:9

Comparison of clinicopathological difference between incidences of female breast cancer during the latest 30 years in partial area of Shanghai
下载PDF
导出
摘要 目的分析上海市部分地区1978~2007年女性乳腺癌发病情况与临床病理特点的变化趋势,为探索乳腺癌防治措施提供理论基础。方法收集1978年~2007年间长海医院病理科诊断的原发性女性乳腺癌病例共计2548例,以每5年为一个时期对乳腺癌的发病情况和临床病理进行回顾性分析和比较。结果 30年来,该地区乳腺癌病例数增长了511%,乳腺癌占病理检验总量的比例、乳腺肿瘤中恶性肿瘤所占比例均上升。乳腺癌的发病年龄逐期上升,最后1个时期发病平均年龄达53.55岁,与前5个时期相比差异有显著性。浸润性非特殊癌的比例从第1个时期的73.33%上升到第5个时期的84.64%,而最后一个时期又下降到79.28%,非浸润性癌及早期浸润性癌的比例上升。小体积肿瘤和淋巴结转移阴性病例比例持续上升。结论 30年来,该地区乳腺癌发病率呈快速上升趋势,发病年龄呈现老龄化。乳腺癌早期检出率上升,肿瘤恶性比例及浸润性非特殊癌比例也呈现上升趋势。 Purpose To clarify whether or not marked changes in the social environment during the past 30 years in Shanghai have altered the epidemiology and clinicopathologic characteristics of female primary breast cancer.Methods 2 548 cases of female primary breast cancers diagnosed in the Changhai Hospital were retrieved.Comparison of clinicopathologic characteristics of breast cancer in each period(5 years as a period) were conducted.Results The number of breast cancers diagnosed increased by 511% during the past 30 years,the proportion of breast cancer in the total amount of surgically pathologic cases and the malignant proportion of breast tumor were also increased.The age at onset of the last period showed significantly different from the previous 5 periods.The proportion of nonspecific invasive breast carcinoma increased from 73.33% in 1st period to 84.64% in 5th period,but decreased to 79.28% in 6th period,and non-invasive and micro-invasive carcinoma increased year by year.More and more carcinoma with small size and lymph node-negative cases appeared.Conclusions In the past 30 years,the incidence of breast cancer in this area reveals marked increase,and the age at onset becomes older though the detection rate of early stage carcinoma has increased.The trend of the malignant proportion of breast tumor and the proportion of nonspecific invasive breast carcinoma are also increasing.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2010年第5期528-531,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 乳腺肿瘤 临床病理 流行病学 breast neoplasms clinicopathology epidemiology
  • 相关文献

参考文献13

二级参考文献53

共引文献162

同被引文献92

  • 1刘山,黄晓蓉,易瑛.近20年乳腺癌发病的常见危险因素变化分析[J].华西医学,2007,22(4):729-730. 被引量:11
  • 2张毅,姜军,杨新华,封传悦.老年乳腺癌ER、PR表达及其与临床病理的关系[J].第三军医大学学报,2007,29(5):454-456. 被引量:22
  • 3Misra S, Solomon NL, Moffat FL, Koniaris LG. Screening criteria for breast cancer. Adv Surg,2010,44:87 - 100.
  • 4刘红,荀培,陈可欣,李海欣,郝希山.天津市近20年女性乳腺癌患者临床病理特点及预后变化趋势分析[J].中华医学杂志,2007,87(34):2405-2407. 被引量:13
  • 5Alwaili K, Alrasadi K, Awan Z, et al. Approach to the diagnosis and management of lipoprotein disorders [J]. Curr Opin Endocrinol Diabetes Obes, 2009, 16(2): 132-140.
  • 6Therond P. Catabolism of lipoproteins and metabolic syndrome [J]. Curt Opin Endocrinol Diabetes obes, 2009,12(4):366-371.
  • 7Willemsen AE, van Herpen CM, Wesseling P, et al. Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line pall- iative treatment for metastasized ductal breast carcinoma [J]. Acta oncol, 2011, 50(3):462-465.
  • 8Duraker N, Demir D, Bati B, et al. Survival benefit of post-mastecto- my radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis[J]. Jpn J Clin Oneol, 2012, 42 (7):601-608.
  • 9Xu Q, Xu N, Fang W, et al. Complete remission of platinum-refracto- ry primary Fallopian tube carcinoma with third-line gemcitabine plus cisplatin: A case report and review of the literature [J]. Oneol Lett, 2013, 5(5): 1601-1604.
  • 10Leonardi V, Palmisano V, Pepe A, et al. Docetaxel and gemcitabine in the treatment of metastatic breast carcinoma: a dose finding study [J]. Tumori, 2009, 95(4):427-431.

引证文献9

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部